Addicted to proteostasis: How KRAS-driven cancers acquire resistance to clinical KRAS inhibitors.

Klein, Austin T; Mendillo, Marc L

Klein, Austin T; Mendillo, Marc L.

Afiliación

Klein AT; Deptartment of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Mendillo ML; Deptartment of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: mendillo@northwestern.edu.

Cell Chem Biol ; 30(11): 1334-1336, 2023 11 16.

Article en En | MEDLINE | ID: mdl-37977128

Asunto(s)

Neoplasias; Proteostasis; Humanos; Proteínas Proto-Oncogénicas p21(ras)/genética; Inhibidores de Proteínas Quinasas/farmacología; Inhibidores de Proteínas Quinasas/uso terapéutico; Neoplasias/tratamiento farmacológico; Transducción de Señal; Mutación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteostasis / Neoplasias Límite: Humans Idioma: En Revista: Cell Chem Biol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google